SRPTLawsuits•prnewswire•
INVESTOR DEADLINE MONDAY: Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - SRPT
Sentiment:Negative (-65)
Summary
SAN DIEGO, Aug. 22, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) securities between June 22, 2023 and June 24, 2025, inclusive (the "Class Period"), have until this Monday, August 25, 2025 to seek...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 22, 2025 by prnewswire